Toronto Dominion Bank’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-41
Closed -$344 1370
2024
Q2
$344 Sell
41
-83
-67% -$669 ﹤0.01% 1285
2024
Q1
$1.06K Buy
124
+86
+226% +$718 ﹤0.01% 1216
2023
Q4
$323 Buy
+38
New +$361 ﹤0.01% 1381
2023
Q3
Sell
-29
Closed 1886
2023
Q2
$0 Sell
29
-83
-74% -$1.03K ﹤0.01% 1730
2023
Q1
$1K Buy
+112
New +$1.3K ﹤0.01% 1390
2022
Q3
Sell
-37
Closed 1678
2022
Q2
$0 Sell
37
-374
-91% -$2.96K ﹤0.01% 1759
2022
Q1
$4K Buy
411
+401
+4,010% +$3.86K ﹤0.01% 1289
2021
Q4
$0 Sell
10
-466
-98% -$5.82K ﹤0.01% 1897
2021
Q3
$7K Buy
476
+274
+136% +$4.17K ﹤0.01% 1293
2021
Q2
$3K Sell
202
-275
-58% -$5.12K ﹤0.01% 1291
2021
Q1
$10K Buy
477
+132
+38% +$3.17K ﹤0.01% 1295
2020
Q4
$7K Buy
345
+63
+22% +$1.16K ﹤0.01% 1238
2020
Q3
$5K Buy
282
+172
+156% +$2.73K ﹤0.01% 1118
2020
Q2
$2K Buy
+110
New +$1.39K ﹤0.01% 1177

Other funds holding PROF

Toronto Dominion Bank's PROF Position: Q3 2024 in Review

Toronto Dominion Bank sold out of Profound Medical (PROF) in Q3 2024, closing a stake of 41 shares — an estimated $344 sold.

Toronto Dominion Bank first reported a position in PROF in Q2 2020 and held it in 14 quarters. The position peaked at $10K in Q1 2021. 44 funds tracked by Wall St. Rank hold PROF as of Q3 2024.

  • Toronto Dominion Bank reported no remaining Profound Medical position as of Q3 2024 after selling out during the quarter.
  • Toronto Dominion Bank sold 41 Profound Medical shares in Q3 2024, an estimated $344.
  • Toronto Dominion Bank first reported a position in Profound Medical in Q2 2020 and held it in 14 quarters.
  • Toronto Dominion Bank's Profound Medical position peaked at $10K in Q1 2021.
  • 44 funds tracked by Wall St. Rank held Profound Medical as of Q3 2024.

Based on Toronto Dominion Bank's 13F filing for Q3 2024, filed 14 Nov 2024.